Sunday, 27 February 2022

A Key Step in the Direction of TB Elimination from the World: Management of Latent Tuberculosis Infection | Chapter 11 | Emerging Trends in Disease and Health Research Vol. 3

 The organism's infection Because a healthy person's immune system avoids disease, Mycobacterium Tuberculosis (MTB) may not produce clinical disease in the majority of people. However, the bacteria can still be found in the body in a form known as Latent Tuberculosis Infection (LTBI), which can cause disease if the immune system is compromised owing to causes such as diabetes, chronic use of steroids, HIV, and other factors. This article tries to concentrate on the diagnosis and treatment of LTBI. Due to infection rates as high as 40% of the population in places like India, treating all afflicted with LTBI may not be practical. However, in high-risk scenarios, focused therapy of LTBI is a viable alternative. The drug(s) used in LTBI therapy has changed dramatically, as will be discussed in this chapter.



Author(S) Details

S. Amit
National Institute of Tuberculosis and Respiratory Diseases, India.

A. Puneet
National Institute of Tuberculosis and Respiratory Diseases, India.

S. Prabhpreet
National Institute of Tuberculosis and Respiratory Diseases, India.

View Book:- https://stm.bookpi.org/ETDHR-V3/article/view/5886

No comments:

Post a Comment